TABLE 2
Ex vivo binding analysis after a single oral administration of Lu AA33810 in rats
All tissues were collected 1 h postdose. Plasma and brain samples were analyzed for exposure levels of Lu AA33810. Brain sections through the caudate putamen were analyzed for specific binding using the Y5 receptor-selective radioligand [35S]Lu AE66516. The reduction in specific binding of [35S]Lu AE66516 (relative to maximal values in vehicle-treated controls) was used to determine percentage receptor occupancy of Lu AA33810. Data represent mean ± S.E.M. of n = 3 experiments.